IFN-γ inhibition of TRAIL-induced IAP-2 upregulation, a possible mechanism of IFN-γ-enhanced TRAIL-induced apoptosis

Sang Youel Park, Timothy R. Billiar, Dai Wu Seol

Research output: Contribution to journalArticlepeer-review

44 Scopus citations

Abstract

Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a type II transmembrane cytokine molecule of TNF family and a potent inducer of apoptosis. The anticancer activities of TNF family members are often modulated by interferon (IFN)-γ. Thus, we investigated whether IFN-γ enhances TRAIL-induced apoptosis. We exposed HeLa cells to IFN-γ for 12 h and then treated with recombinant TRAIL protein. No apoptosis was induced in cells pretreated with IFN-γ, and TRAIL induced 25% cell death after 3 h treatment. In HeLa cells pretreated with IFN-γ, TRAIL induced cell death to more than 70% at 3 h, indicating that IFN-γ pretreatment sensitized HeLa cells to TRAIL-induced apoptosis. We investigated molecules that might be regulated by IFN-γ pretreatment that would affect TRAIL-induced apoptosis. Western blotting analyses demonstrated that TRAIL treatment increased the level of IAP-2 protein and IFN-γ pretreatment inhibited the upregulation of IAP-2 protein by TRAIL protein. Our data indicate that TRAIL can signal to activate both apoptosis induction and antiapoptotic mechanism, at least, through IAP-2 simultaneously. IFN-γ or TRAIL treatment alone did not change expression of other pro- or antiapoptotic proteins such as DR4, DR5, FADD, Bax, IAP-1, XIAP, Bcl-2, and Bcl-XL. Our findings suggest that IFN-γ may sensitize HeLa cells to TRAIL-induced apoptosis by preventing TRAIL-induced IAP-2 upregulation, and IFN-γ may play a role in anticancer therapy of TRAIL protein through such mechanism.

Original languageEnglish
Pages (from-to)233-236
Number of pages4
JournalBiochemical and Biophysical Research Communications
Volume291
Issue number2
DOIs
StatePublished - 2002
Externally publishedYes

Keywords

  • Apoptosis
  • IAP-2
  • IFN-γ
  • TRAIL

Fingerprint

Dive into the research topics of 'IFN-γ inhibition of TRAIL-induced IAP-2 upregulation, a possible mechanism of IFN-γ-enhanced TRAIL-induced apoptosis'. Together they form a unique fingerprint.

Cite this